Aarti Pharmalabs Limited (AARTIPHARM) — Capital Reinvestment Ratio
Aarti Pharmalabs Limited (AARTIPHARM) has a Capital Reinvestment Ratio of 0.32x as of March 2023, meaning it reinvests 0% of its operating cash flow (Rs1.03 Billion) in capital expenditures (Rs331.54 Million). See Aarti Pharmalabs Limited balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aarti Pharmalabs Limited Capital Reinvestment Ratio (2023–2025)
This chart tracks Aarti Pharmalabs Limited's Capital Reinvestment Ratio across 3 annual periods. Check cash flow reinvestment rate of Aarti Pharmalabs Limited to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Aarti Pharmalabs Limited (2023–2025)
Year-by-year Capital Reinvestment Ratio for Aarti Pharmalabs Limited from 2023 to 2025. For live market cap and broader valuation context, see Aarti Pharmalabs Limited stock valuation.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.21x | Rs3.32 Billion | Rs4.02 Billion | ▲ +32.0% |
| 2024 | 0.92x | Rs2.16 Billion | Rs1.99 Billion | ▲ +101.9% |
| 2023 | 0.45x | Rs2.63 Billion | Rs1.20 Billion | — |